Immunohistochemical analysis of p53 in vulval intraepithelial neoplasia and vulval squamous cell carcinoma

Yazar: Rosenthal, A N, Hopster, D, Ryan, A, Jacobs, I J
Baskı/Yayın Bilgisi 2003

p53 codon 72 polymorphism in vulval cancer and vulval intraepithelial neoplasia

Yazar: Rosenthal, A N, Ryan, A, Hopster, D, Jacobs, I J
Baskı/Yayın Bilgisi 2000

Familial ovarian screening – effective or ineffective?

Yazar: Jacobs, I J, Mackay, J, Menon, U, Skates, S J, Rosenthal, A N, Fraser, L
Baskı/Yayın Bilgisi 2006

Detection of tumour lymphovascular space invasion using dual cytokeratin and CD31 immunohistochemistry

Yazar: Alexander-Sefre, F, Singh, N, Ayhan, A, Salveson, H B, Wilbanks, G, Jacobs, I J
Baskı/Yayın Bilgisi 2003

Three‐dimensional in vitro cell biology models of ovarian and endometrial cancer

Yazar: Grun, B. , Benjamin, E. , Sinclair, J. , Timms, J. F. , Jacobs, I. J. , Gayther, S. A. , Dafou, D. 
Yayımlandı Cell Prolif (2009)

Risk of diagnosis of ovarian cancer after raised serum CA 125 concentration: a prospective cohort study.

Yazar: Jacobs, I. J., Skates, S., Davies, A. P., Woolas, R. P., Jeyerajah, A., Weidemann, P., Sibley, K., Oram, D. H.
Baskı/Yayın Bilgisi 1996

Ultrasound assessment of ovarian cancer risk in postmenopausal women with CA125 elevation

Yazar: Menon, U, Talaat, A, Jeyarajah, A R, Rosenthal, A N, MacDonald, N D, Skates, S J, Sibley, K, Oram, D H, Jacobs, I J
Baskı/Yayın Bilgisi 1999

Serum oestrogen receptor α and β bioactivity are independently associated with breast cancer: a proof of principle study

Yazar: Widschwendter, M, Lichtenberg-Frate, H, Hasenbrink, G, Schwarzer, S, Dawnay, A, Lam, A, Menon, U, Apostolidou, S, Raum, E, Stegmaier, C, Jacobs, I J, Brenner, H
Baskı/Yayın Bilgisi 2009

A model for co-expression pattern analysis of genes implicated in angiogenesis and tumour cell invasion in cervical cancer

Yazar: Van Trappen, P O, Ryan, A, Carroll, M, Lecoeur, C, Goff, L, Gyselman, V G, Young, B D, Lowe, D G, Pepper, M S, Shepherd, J H, Jacobs, I J
Baskı/Yayın Bilgisi 2002

Accumulation of p53 protein is frequent in ovarian cancers associated with BRCA1 and BRCA2 germline mutations.

Yazar: Zweemer, R P, Shaw, P A, Verheijen, R M, Ryan, A, Berchuck, A, Ponder, B A, Risch, H, McLaughlin, J R, Narod, S A, Menko, F H, Kenemans, P, Jacobs, I J
Baskı/Yayın Bilgisi 1999

Molecular evidence for putative tumour suppressor genes on chromosome 13q specific to BRCA1 related ovarian and fallopian tube cancer

Yazar: Jongsma, A P M, Piek, J M J, Zweemer, R P, Verheijen, R H M, Klein Gebbinck, J W T, van Kamp, G J, Jacobs, I J, Shaw, P, van Diest, P J, Kenemans, P
Baskı/Yayın Bilgisi 2002

Tagging single-nucleotide polymorphisms in candidate oncogenes and susceptibility to ovarian cancer

Yazar: Quaye, L, Song, H, Ramus, S J, Gentry-Maharaj, A, Høgdall, E, DiCioccio, R A, McGuire, V, Wu, A H, Van Den Berg, D J, Pike, M C, Wozniak, E, Doherty, J A, Rossing, M A, Ness, R B, Moysich, K B, Høgdall, C, Blaakaer, J, Easton, D F, Ponder, B A J, Jacobs, I J, Menon, U, Whittemore, A S, Krüger-Kjaer, S, Pearce, C L, Pharoah, P D P, Gayther, S A
Baskı/Yayın Bilgisi 2009